Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis

BACKGROUND: Prior studies suggest reduced humoral response to COVID-19 vaccination in immunosuppressed populations. Disease modifying therapies (DMTs) for multiple sclerosis (MS) have variable immunomodulatory effects, and limited data are available for all DMTs. We aimed to determine the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales: Satyanarayan, Sammita, Safi, Neha, Sorets, Tali, Filomena, Susan, Zhang, Yinan, Klineova, Sylvia, Fabian, Michelle, Horng, Sam, Tankou, Stephanie, Miller, Aaron, Krieger, Stephen, Lublin, Fred, Sumowski, James, Katz Sand, Ilana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916835/
https://www.ncbi.nlm.nih.gov/pubmed/35533419
http://dx.doi.org/10.1016/j.msard.2022.103737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916835/
https://www.ncbi.nlm.nih.gov/pubmed/35533419
http://dx.doi.org/10.1016/j.msard.2022.103737

Ejemplares similares